Treatment with Activated Protein C (aPC) Is Protective during the Development of Myocardial Fibrosis: An Angiotensin II Infusion Model in Mice

• Mryanda J. Sopel,

  Affiliation Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

  ⨯
• Nicole L. Rosin,

  Affiliation Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

  ⨯
• Alec G. Falkenham,

  Affiliation Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

  ⨯
• Michael Bezuhly,

  Affiliation Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada

  ⨯
• Charles T. Esmon,

  Affiliations Howard Hughes Medical Institute and Cardiovascular Biology Research Program, Oklahoma City, Oklahoma, United States of America, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America

  ⨯
• Timothy D. G. Lee,

  Affiliations Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

  ⨯
• Robert S. Liwski ,

  * E-mail: rliwski@dal.ca (RSL);jean.legare@cdha.nshealth.ca (J-FL)

  Affiliations Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

  ⨯
• Jean-Francois Légaré

  * E-mail: rliwski@dal.ca (RSL);jean.legare@cdha.nshealth.ca (J-FL)

  Affiliations Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

  ⨯